Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Shaffer

Showing results (121-130 of 176) with videos related to

Pageof 18
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 7, 2017
Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor SelectionSatyajit Kosuri, Tara Wolff, Sean M Devlin, et al.
Blood|May 7, 2025
Phase 1/2 Study of High-Dose Palifermin for GVHD Prophylaxis in Patients Undergoing HLA-Matched Unrelated Donor HCTEduard Schulz, Lauren M Curtis, Noa G Holtzman, et al.
Bone Marrow Transplantation|September 1, 2019
Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignanciesRichard J Lin, Theresa A Elko, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2020
Prognostic Factors for Postrelapse Survival after ex Vivo CD34<sup>+</sup>-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple MyelomaAlexandra Gomez-Arteaga, Gunjan L Shah, Raymond E Baser, et al.
Blood Advances|January 5, 2019
Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adultsRichard J Lin, Patrick D Hilden, Theresa A Elko, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 5, 2019
Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34<sup>+</sup> Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Valkal Bhatt, Patrick Hilden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2017
KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell TransplantationJeanette E Boudreau, Fabio Giglio, Ted A Gooley, et al.
Journal of Child and Adolescent Psychopharmacology|December 9, 2024
Results from a Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Trial of Lovastatin or Minocycline in Fragile X SyndromeWalker S McKinney, Lauren M Schmitt, Lisa A De Stefano, et al.
Plos One|May 20, 2025
Frontal cortex hyperactivation and gamma desynchrony in Fragile X syndrome: Correlates of auditory hypersensitivityErnest V Pedapati, Lauren E Ethridge, Yanchen Liu, et al.
Transplantation and Cellular Therapy|June 9, 2026
Tuberculosis After Allogeneic Hematopoietic Cell Transplant: A 15-Year Case Series Highlighting Diagnostic ChallengesCesar Figueroa-Ortiz, Scott Schoninger, June L Chan, et al.
Pageof 18

Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 7, 2017
Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor SelectionSatyajit Kosuri, Tara Wolff, Sean M Devlin, et al.
Blood|May 7, 2025
Phase 1/2 Study of High-Dose Palifermin for GVHD Prophylaxis in Patients Undergoing HLA-Matched Unrelated Donor HCTEduard Schulz, Lauren M Curtis, Noa G Holtzman, et al.
Bone Marrow Transplantation|September 1, 2019
Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignanciesRichard J Lin, Theresa A Elko, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2020
Prognostic Factors for Postrelapse Survival after ex Vivo CD34<sup>+</sup>-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple MyelomaAlexandra Gomez-Arteaga, Gunjan L Shah, Raymond E Baser, et al.
Blood Advances|January 5, 2019
Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adultsRichard J Lin, Patrick D Hilden, Theresa A Elko, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 5, 2019
Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34<sup>+</sup> Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Valkal Bhatt, Patrick Hilden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2017
KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell TransplantationJeanette E Boudreau, Fabio Giglio, Ted A Gooley, et al.
Journal of Child and Adolescent Psychopharmacology|December 9, 2024
Results from a Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Trial of Lovastatin or Minocycline in Fragile X SyndromeWalker S McKinney, Lauren M Schmitt, Lisa A De Stefano, et al.
Plos One|May 20, 2025
Frontal cortex hyperactivation and gamma desynchrony in Fragile X syndrome: Correlates of auditory hypersensitivityErnest V Pedapati, Lauren E Ethridge, Yanchen Liu, et al.
Transplantation and Cellular Therapy|June 9, 2026
Tuberculosis After Allogeneic Hematopoietic Cell Transplant: A 15-Year Case Series Highlighting Diagnostic ChallengesCesar Figueroa-Ortiz, Scott Schoninger, June L Chan, et al.
Pageof 18